Clinical Trial Update: Cytochrome P450 2E1 and Iron Overload [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the role of cytochrome P450 2E1 in iron overload and insulin resistance has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin Resistance
• Iron Overload

Snippet

Sponsor: Rennes University Hospital | Conditions: Insulin Resistance, Iron Overload | Phase 2 | Status: COMPLETED